Novartis has received approval from the U.S. Food and Drug Administration for Itvisma, a treatment for spinal muscular atrophy. Dr. John Day is professor of neurology and pediatrics, director of the ...

Novartis has received an FDA approval for Itvisma, a new version of the company’s gene therapy Zolgensma, to treat older patients with spinal muscular atrophy (SMA). The approval comes more than six ...

ITZY’s Yuna will be starring in tvN’s new drama “My Favorite Employee” (literal title)! On November 24, a source from tvN shared, “Yuna has been cast in ‘My Favorite Employee’ and recently completed ...

ITZY has won their first music show trophy for their new title track “TUNNEL VISION”! On the November 21 episode of KBS 2TV’s “Music Bank,” the candidates for first place were CLOSE YOUR EYES’ “X” and ...

Members Yeji, Ryujin, Lia, Chaeryeong and Yuna detail their 11th EP 'Tunnel Vision' courtesy of JYP Entertainment When ITZY got back in the studio to record their upcoming EP, they were ready to ...

The fund has returned 32.41 percent over the past year, 26.89 percent over the past three years, and 13.94 percent over the past five years.

Investor and advisor interest in separately managed accounts is surging. While mutual funds, exchange-traded funds, as well as individual stocks and bonds still dominate advisor platforms, SMAs are ...

Helena's SMA Architecture and Design announced its merger with A&E Design Oct. 6 to highlight their shared values and efforts to support Montana communities.

SMA Solar Technology AG said its Sunny Central Storage battery inverter has become the first system in Germany to receive a unit certificate for grid-forming mode with instantaneous reserve. The ...

SMA management expects negative one-time losses between €170-220 million. Image: SMA Solar. SMA Solar has forecast financial losses and further restructuring measures in 2025, as it responds to ...

SMA type 2, previously known as Dubowitz disease, is a hereditary disease that affects motor neurons. It typically becomes noticeable around the ages of 6 to 18 months, when children with the ...